Search

Search Constraints

You searched for: Author/Creator Satoh, Takefumi

Search Results

1. Abiraterone acetate after progression with enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: a multi-center retrospective analysis. (December 2016)

2. Bone dissemination of prostate cancer after holmium laser enucleation of the prostate: A case report and a review of the literature. (15th August 2013)

5. Impact of five‐tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high‐dose‐rate brachytherapy. Issue 15 (14th September 2017)

6. Long‐term outcomes of combining prostate brachytherapy and metastasis‐directed radiotherapy in newly diagnosed oligometastatic prostate cancer: A retrospective cohort study. Issue 5 (26th December 2018)

7. Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external‐beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open‐label, randomized, phase 3 trial. Issue 17 (23rd June 2020)

8. Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial. (1st May 2021)

9. PD22-05 COMPARISON OF LOW-DOSE-RATE BRACHYTHERAPY VERSUS RADICAL PROSTATECTOMY IN PATIENTS WITH INTERMEDIATE-RISK PROSTATE CANCER: A PROPENSITY-MATCHED MULTI-INSTITUTIONAL STUDY. (May 2022)

10. Quality of life outcomes after low dose‐rate brachytherapy for localized prostate cancer: Current status and future perspectives. (22nd August 2019)